Robert W. Duggan - 23 May 2022 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Executive Officer, Director
Signature
/s/ Robert W. Duggan_
Issuer symbol
SMMT
Transactions as of
23 May 2022
Net transactions value
$0
Form type
4
Filing time
25 May 2022, 20:45:34 UTC
Previous filing
23 May 2022
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Other +21,135 +0.03% 67,683,589 23 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Common Stock were collateral for a loan made by the Reporting Person to a third party, and were transferred to the Reporting Person in full satisfaction of the loan.